AffaMed Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and commercializing transformative medical devices and pharmaceutical products that address critical unmet medical needs in ophthalmology for patients in Greater China and around the world. The management team of AffaMed Therapeutics has deep industry expertise and an extensive track record in high-quality clinical development, regulatory affairs, CMC, business development, and operations both in China and with leading global pharmaceutical companies.
AffaMed is well-positioned to accelerate clinical development of potential new therapies that aim to make a tangible difference in patients' lives.
To Help More Patients Access Innovative Treatments
To Become a Leading Ophthalmology Company with Innovative Therapeutics for China and the World
